Growth Company Investor - WH Ireland flag Imaginatik as speculative buy

AIM-quoted technology group Imaginatik, the developer of innovation and problem-solving software, was flagged up as a speculative buy, on the news that pharmaceuticals giant and client Pfizer is investing up to £500,000 in the business, as well as buying 10,000 new software licences. The company’s software is now used by more than 50 blue-chip clients in Europe and North America and, with a strengthened balance sheet (and even after the dilutive effect of the shares issued to Pfizer), the broker, WH Ireland, considers the 6.12p shares ’still continue to trade on prospective price-to-earnings multiples that are undemanding for a software company with such excellent growth prospects’.